Laboratory Corporation of America Holdings (LH)

NYSE: LH · IEX Real-Time Price · USD
216.57
+3.05 (1.43%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Company Description

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.

It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings.

In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing.

It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent c

Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings logo
Country United States
Founded 1971
Industry Diagnostics & Research
Sector Healthcare
Employees 67,000
CEO Adam H. Schechter

Contact Details

Address:
358 S Main St
Burlington, North Carolina 27215
United States
Phone (336) 229-1127
Website labcorp.com

Stock Details

Ticker Symbol LH
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000920148
CUSIP Number 50540R409
ISIN Number US50540R4092
Employer ID 13-3757370
SIC Code 8071

Key Executives

Name Position
Adam H. Schechter President, Chief Executive Officer and Chairman
Glenn A. Eisenberg Chief Financial Officer and Executive Vice President
Mark S. Schroeder Executive Vice President, President of Diagnostics Laboratories and Chief Operating Officer
Dr. Brian J. Caveney J.D., M.D., M.P.H. EVice President, President of Early Development Research Laboratories and Chief Medical Officer
Peter J. Wilkinson Senior Vice President and Chief Accounting Officer
Lance V. Berberian Executive Vice President and Chief Information and Technology Officer
Dr. Marcia T. Eisenberg Ph.D. Chief Scientific Officer and Senior Vice President
Christin O'Donnell Vice President of Investor Relations
Sandra D. van der Vaart Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Amy B. Summy Executive Vice President and Chief Marketing Officer

Latest SEC Filings

Date Type Title
Mar 27, 2024 8-K Current Report
Mar 7, 2024 144 Filing
Mar 7, 2024 144 Filing
Feb 26, 2024 10-K Annual Report
Feb 21, 2024 144 Filing
Feb 21, 2024 144 Filing
Feb 15, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 144 Filing
Feb 8, 2024 144 Filing